Statutory Instruments
2005 No. 2750
MEDICINES
The Medicines (Traditional Herbal Medicinal Products for Human Use) Regulations 2005
Made
6th October 2005
Laid before Parliament
7th October 2005
Coming into force
Except for the purposes of paragraphs 4(2)(a) and 8(a)(i) of Schedule 7
30th October 2005
For the purposes of paragraphs 4(2)(a) and 8(a)(i) of Schedule 7
20th November 2005
Citation, commencement and extent
1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Interpretation
2. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Responsibility for Member States' functions in relation to traditional herbal medicinal products
3. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Traditional herbal registrations for traditional herbal medicinal products
4. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Applications for the grant or renewal of a traditional herbal registration
5. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Consideration, and grant or refusal, of an application for, or for renewal or variation of, a traditional herbal registration
6. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Revocation, suspension or variation of a traditional herbal registration or the suspension of the use or marketing of traditional herbal medicinal products
7. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Urgent safety restrictions
8. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Obligations of holders of traditional herbal registrations, and offences by holders of traditional herbal registrations and other persons
9. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Consequential and other amendments of the Act and other enactments
10. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Application of enforcement provisions of the Act
11. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Other Schedules to have effect
12.The following Schedules shall have effect, namely Schedule 5 (labels), Schedule 6 (transitional provision) and Schedule 7 (consequential amendments to orders and regulations).
Signed by authority of the Secretary of State for Health
Warner
Minister of State,
Department of Health
6th October 2005
Regulation 4(2)
SCHEDULE 1EXEMPTIONS AND EXCEPTIONS FROM THE PROVISIONS OF REGULATION 4
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Regulations 6(2), 7(7)
SCHEDULE 2PROCEDURAL PROVISIONS RELATING TO THE GRANT, RENEWAL, VARIATION, REVOCATION AND SUSPENSION OF TRADITIONAL HERBAL REGISTRATIONS
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Regulation 9(6)
SCHEDULE 3OFFENCES, PENALTIES ETC
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Regulation 11(2)(a)
SCHEDULE 4MODIFICATIONS OF ENFORCEMENT PROVISIONS OF THE ACT
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Regulation 12
SCHEDULE 5LABELS
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Regulation 12
SCHEDULE 6TRANSITIONAL PROVISION
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Regulation 12
SCHEDULE 7CONSEQUENTIAL AMENDMENTS TO ORDERS AND REGULATIONS
1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
4. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
5. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
6. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
7. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
8. In the Unlicensed Medicinal Products for Human Use (Transmissible Spongiform Encephalopathies) (Safety) Regulations 2003(3), in regulation 1 (citation, commencement and interpretation), in paragraph (2)—
(a)in the definition of “unlicensed product”—
(i)in sub-paragraph (a)(ii) after “Medicinal Products” insert “or under Regulation
(ii). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(iii). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(b)in the definition of “the TSE Guideline” after “for human use” insert “as substituted by Commission Directive
S.I. 1972/1811.
Directive 2001/83/EC of the European Parliament and of the Council of 6th November 2001 on the Community code relating to medicinal products for human use, OJ L311, 28.11.2001, p 67.
OJ No. L136, 30.4.2004, p.85.